Background:

Disease stratification practices have long been used as a means to produce and make sense of  cancer, distinguishing ‘types’, tumour development stages, and even patients’ sociodemographic profiles. However, interest in stratification; that is, the process of dividing oncology populations into clinically meaningful subtypes, has been re-invigorated by two recent developments in medicine and healthcare. First, an increased awareness of …